Synbiotics could not reduce the Scoring of Childhood Atopic Dermatitis (SCORAD): A randomized double blind placebo-controlled trial

Iranian Journal of Allergy, Asthma and Immunology

Volumn 10, Issue 1, 2011, Pages 21-28

  Shaflei, Alireza ^a   Moin, Mostafa ^a,b   Pourpak, Zahra ^a,b   Gharagozlou, Mohammad ^a   Aghamohamadi, Asghar ^a   Sajedi, Vahid ^a   Soheili, Habib ^a   Sotoodeh, Soheila ^a   Movahedi, Masoud ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Atopy; Dermatitis; Infants; Prebiotics

Indexed keywords

ALLERGEN; HYDROCORTISONE; IMMUNOGLOBULIN E; LANOLIN ALCOHOL; PLACEBO; PREBIOTIC AGENT; PROBIOTIC AGENT; SYNBIOTIC AGENT;

ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; EOSINOPHIL COUNT; FEMALE; HUMAN; INFANT; MALE; PRICK TEST; RANDOMIZED CONTROLLED TRIAL; SKIN; SUPPLEMENTATION;

CHILD, PRESCHOOL; DERMATITIS, ATOPIC; DOUBLE-BLIND METHOD; EOSINOPHILS; FEMALE; HUMANS; IMMUNOGLOBULIN E; INFANT; INTRADERMAL TESTS; IRAN; MALE; PLACEBO EFFECT; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; SYNBIOTICS; TIME FACTORS; TREATMENT OUTCOME;

EID: 79952462588     PISSN: 17351502     EISSN: 17355249     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Beattie PE, Lewis-Jones MS. A comparative study of impairment of Quality Of Life (QOL) in children with skin disease and children with other chronic childhood diseases. Br J Dermatol 2006; 155:145-5.
2. Boguniewicz M, Abramovits W, Paller A, Whitaker-Worth DL, Prendergast M, Cheng JW, et al. A multiple-domain framework of clinical, economic, and patient-reported outcomes for evaluating benefits of intervention in atopic dermatitis. J Drugs Dermatol 2007; 6(4):416-3.
3. Mancini AJ, Kaulback K, Chamlin SL. The socioeconomic impact of atopic dermatitis in the United States: a systematic review. Pediatr Dermatol 2008; 25(1):1-6. (Pubitemid 351315442)
4. Mozaffari H, Pourpak Z, Pourseyed S, Farhoodi A, Aghamohammadi A, Movahadi M, et al. Quality of life in atopic dermatitis patients. J Microbiol Immunol Infect 2007; 40(3):260-4 (Pubitemid 47518731)
5. Bergmann RL, Edenharter G, Bergmann KE, Forster J, Bauer CP, Wahn V, et al. Atopic dermatitis in early infancy predicts allergic airway disease at 5 years. Clin Exp Allergy1998; 28(8):965-70.
6. Pourpak Z, Mozaffari H, Gharagozlou M, Daneshmandi Z, Moin M. Asthma in patients with atopic dermatitis. Indian J Pediatr 2008; 75(2):139-41. (Pubitemid 351866420)
7. ISAAC Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhino conjunctivitis and atopic eczema: ISAAC. Lancet 1998; 351:1225-32.
8. Sonia M. The role of Probiotics in allergic diseases. Allergy Asthma Clin Immunol 2009; 5(1):5.
9. Ji GE. Probiotics in primary prevention of atopic dermatitis. Forum Nutr 2009; 61:117-28.
10. Strachan DP, Hay fever, hygiene, and household size, BMJ 1989; 299:1259-60.
11. Holt PG. Postnatal maturation of immune competence during infancy and childhood. Pediatr Allergy Immunol 1995; 6(2):59-70.
12. Bloomfield SF, Stanwell-Smith R, Crevel RW, Pickup J. Too clean, or not too clean: the hygiene hypothesis and home hygiene. Clin Exper Allergy 2006; 36(4):402-25.
13. Schaub B, Lauener R, Von Mutius E. The many faces of the hygiene hypothesis. J Allergy Clin Immunol 2006; 117(5):969-77.
14. Simon GL, Gorbach SL. Intestinal flora in health and disease. Gastroenterology 1984; 86(1):174-93 (Pubitemid 14177335)
15. Björkstén B. Genetic and environmental risk factors for the development of food allergy, Curr Opin Allergy Clin Immunol 5 (2005), pp. 249-53.
16. Björkstén B, Naaber P, Sepp E, Mikelsaar M. The intestinal microflora in allergic Estonian and Swedish 2- year-old children. Clin Exp Allergy 1999; 29(3):342-6. (Pubitemid 29145134)
17. Kalliomäki M, Kirjavainen PV, Eerola E, Kero P, Salminen SJ, Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing, J Allergy Clin Immunol 2001; 107(1):129-34. (Pubitemid 32105256)
18. Sepp E, Julge K, Vasar M, Naaber P, Björkstén B, Mikelsaar M. Intestinal microflora of Estonian and Swedish infants, Acta Paediatr 1997; 86(9):956-61. (Pubitemid 27425591)
19. Adlerberth I, Carlsson B, de Man P, Jalil F, Khan SR, Larsson P, et al. Intestinal colonization with Enterobacteriaceae in Pakistani and Swedish hospital delivered infants, Acta Paediatr 1991; 80(6-7):602-10.
20. (WHO), FaAOFotUNaWHO: Guidelines for the Evaluation of Probiotics in Food. Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food. Accessed on December 7, 2006.
21. Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomized placebo-controlled trial, Lancet 2003; 361(9372):1869-71. (Pubitemid 36645184)
22. Viljanen M, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, et al. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial, Allergy 2005; 60(4):494-500. (Pubitemid 40332976)
23. Sistek D, Kelly R, Wickens K, Stanley T, Fitzharris P, Crane J. Is the effect of probiotics on atopic dermatitis confined to food sensitized children? Clin Exp Allergy 2006; 36(5):629-33.
24. Bjorksten B, Sepp E, Julge K, Voor T, Mikelsaar M. Allergy development and the intestinal microflora during the first year of life, J Allergy Clin Immunol 2001; 108(4):516-20. (Pubitemid 32978019)
25. Kunz B, Oranje AP, Labréze L, Staldor JF, Ring J, Taiieb A. Clinical validation and guidelines for the SCORAD Index: Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 1997; 195(1):10-9. (Pubitemid 27326702)
26. Kailasapathy K, Chin J. Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol C ell Biol 2000; 78:80-8. (Pubitemid 30090993)
27. Michail S, Onady G, Stolfi A, Johnson T. Efficacy of probiotics in treatment ofpediatric atopic dermatitis a meta-analysis of randomized, controlled trials 2008; 101(5):508-16
28. Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997; 99(2):179-85. (Pubitemid 27091565)
29. Kirjavainen PV, Arvola T, Salminen SJ, Isolauri E. Aberrant composition of gut microbiota of allergic infants. a target of bifidobacterial therapy at weaning? Gut 2002; 51(1):51-5.
30. Passeron T, Lacour JP, Fontas E, Ortonne JP. Prebiotics and synbiotics. two promising approaches for the treatment of atopic dermatitis in children above 2 years. Allergy 2006; 61(4):431-7. (Pubitemid 43334111)
31. Rosenfeldt V, Benfeldt E, Nielsen SD, Michaelsen KF, Jeppesen DL, Valerius NH, et al. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 2003; 111(2):389-95. (Pubitemid 36228562)
32. Brouwer ML, Wolt-Plompen SA, Dubois AE, van der Heide S, Jansen DF, Hoijer MA, et al. No effects of probiotics on atopic dermatitis in infancy. a randomized placebo-controlled trial. Clin Exp Allergy 2006; 36(7):899-906. (Pubitemid 43972956)
33. Fölster-Holst R, Müller F, Schnopp N, Abeck D, Kreiselmaier I, Lenz T, et al. Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis. Br J Dermatol 2006; 155(6):1256-61. (Pubitemid 44730004)
34. Farid R, Jabbari F, Ahanchian H, Moghiman T. Clinical and immunogical Effect of Probiotic in childhood Atopic Dermatitis. J Allergy Clin Immunol 2010; 125(2 ,suppl 1):AB93.